⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30488643 | 0.70 | — | — | |
| SCHEMBL30355297 | 0.68 | — | — | |
| SCHEMBL29813305 | 0.67 | — | — | |
| SCHEMBL30488656 | 0.61 | — | — | |
| SCHEMBL10085128 | 0.59 | MAPT (0.41) | — | |
| SCHEMBL12447056 | 0.58 | CES1 (0.30) | — | |
| SCHEMBL793199 | 0.58 | CES1 (0.30) | — | |
| SCHEMBL17424522 | 0.54 | TMIGD3 (0.34) | — | |
| SCHEMBL14882885 | 0.52 | ALDH1A1 (0.36) | — | |
| SCHEMBL10085124 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040555-A | CXCR4 targeted dimer molecular probe and preparation method and application thereof | 哈尔滨医科大学 | 2025-05-27 | — | — | CN | claimed |
| EP-3941459-B1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | STINGRAY THERAPEUTICS INC (US) | 2026-05-06 | — | — | EP | disclosed |
| CN-120040555-A | CXCR4 targeted dimer molecular probe and preparation method and application thereof | 哈尔滨医科大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119874628-A | Nitrogen-containing compound and preparation method and application thereof | 上海深景医药科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-11407729-B2 | Quinoline and quinazoline compounds and methods of use thereof | Stingray Therapeutics, Inc. (US) | 2022-08-09 | — | — | US | disclosed |
| EP-3941459-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | Stingray Therapeutics, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |